ZeClinics

Barcelona, Spain Founded: 2013 • Age: 13 yrs
Zebrafish models for toxicity studies are developed by ZeClinics CRO.
Annual revenue - Latest available
Total funding - 7 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About ZeClinics

ZeClinics is a company based in Barcelona (Spain) founded in 2013. ZeClinics operates in a competitive market with competitors including TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.

  • Headquarter Barcelona, Spain
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $108.22 K (USD), Grant

    Oct 01, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ZeClinics

  • Total Funding
  • Total Rounds 7
  • Last Round Grant — $108,225
  • First Round

    (01 Jan 2017)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2022 Amount Grant - ZeClinics Valuation

investors

Jan, 2020 Amount Grant - ZeClinics Valuation

investors

Oct, 2019 Amount Grant - ZeClinics Valuation

investors

Investors in ZeClinics

ZeClinics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location

Investments & Acquisitions by ZeClinics

Investments

Financial Statements - ZeClinics

Zeclinics Comparisons

+
Add Comparison
Available on Premium

Competitors of ZeClinics

ZeClinics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Humanized mouse models are developed for preclinical immune drug studies.
domain founded_year HQ Location
Provider of transgenic rodent models and customized cell lines for preclinical development
domain founded_year HQ Location
Preclinical CRO services for CNS and orphan disorders are offered.
domain founded_year HQ Location
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
domain founded_year HQ Location
Animal models are supplied for in-vivo analytical services.
domain founded_year HQ Location
Preclinical contract research organization offering standard GLP and non-GLP services

Latest news on Zeclinics

Frequently Asked Questions about ZeClinics

ZeClinics was founded in 2013 and raised its 1st funding round 4 years after it was founded.

ZeClinics is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.

ZeClinics was founded in 2013 and is based in Barcelona, Spain, where support from University Pompeu Fabra and incubation at Barcelona Biomedicine Research Park are provided. Operations focus on contract research organization services in the biotech sector, including toxicity, efficacy, and genesis assays conducted on zebrafish with CRISPRCas9 technology. Proprietary models developed by the company have been licensed to institutions such as Harvard, MIT, and the Broad Institute.

ZeClinics's top competitors include GenOway, PsychoGenics and Alpha Genesis.

ZeClinics has 2 investors. Key investors include European Union, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available